BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2002
View Archived Issues
Phase I trial initiated for HER-2 vaccine for breast cancer
Read More
Aradigm and geneRx+ collaborate on pulmonary-delivered gene therapeutics
Read More
Enrollment completed in phase IIA kidney transplantation trial of ISA-247
Read More
Novel PPARalpha agonists under study at Pfizer
Read More
Mercian and Eisai describe the isolation of new antiangiogenic agents from fungal cultures
Read More
ChondroGene and Pfizer enter osteoarthritis collaboration
Read More
BMS patent covers novel anti-HIV agents
Read More
Merck scientists present two series of thrombin inhibitors
Read More
InterMune and Inhale to develop PEGylated Infergen
Read More
EP4 receptor modulators and their use in neuropathic pain
Read More
New inhibitors of advanced glycation end products reported by Meiji Seika
Read More
Lexicon Genetics drug target may have potential in arthritis and autoimmune disease
Read More
Duloxetine reported safe and effective in major depressive disorder
Read More
Phase III trial evaluates E2F Decoy for prevention of coronary artery bypass graft failure
Read More
Extensive evaluation of once-daily methylphenidate (Concerta) in ADHD continues
Read More
New preclinical and clinical data on gepirone in major depression
Read More
WX-UK1 enters first clinical trial in cancer patients
Read More
Neurocrine Biosciences and Taisho restructure NBI-6024 agreement
Read More
PrimeBoost melanoma pharmaccine advances to phase II testing
Read More
MediGene and Evotec team up to form new company
Read More
Orphan drug grant will help defray the costs of clinical studies with MTC-DOX
Read More
Rheumatoid arthritis patients in need may receive adalimumab under the ACT program
Read More
Indications for Glucovance broadened by FDA
Read More
Novel oxazolidinones obtained at Versicor with expanded spectrum of antibacterial activity
Read More
Mechanism underlying contraceptive effect of ZK-137316 evaluated in monkeys
Read More